| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Ani Pharmaceuticals, Inc. (ANIP) has 15 insiders with recent SEC Form 4 filings, including 0 buys and 23 sells. ANIP is classified in the Pharmaceuticals industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| COO | 431.9K | $35.26M | - | |
| CEO | 411.2K | $33.57M | - | |
| CFO | 230.9K | $18.85M | - | |
| VP | 158.5K | $12.94M | - | |
| Other | 91.3K | $7.45M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Mar 19, 2018 | Raynor Daniel | Director | Sell | 7,215 | $60.85 | $439,047.06 | -1.2% | |
| Mar 14, 2018 | Marshbanks Tracy | Director | Sell | 1,912 | $63.10 | $120,647.20 | -0.4% | |
| Mar 14, 2018 | Raynor Daniel | Director | Sell | 27,964 | $62.24 | $1,740,552.05 | -2.3% | |
| Mar 14, 2018 | Przybyl Arthur | President And CEO | Sale+OE | 40,000 | $61.83 | $2,473,142.75 | -6.4% | |
| Mar 12, 2018 | Marshbanks Tracy | Director | Sell | 64,221 | $63.03 | $4,047,887.96 | -4.1% | |
| Mar 5, 2018 | Marken James G.47 | SVP Ops &Prod Dev | Sale+OE | 4,177 | $61.92 | $258,639.84 | -6.0% | |
| Mar 1, 2018 | Schrepfer Robert W | SVP - New Bus Dev &Spec Sales | Sale+OE | 28,652 | $61.66 | $1,766,770.84 | -24.6% | |
| Mar 1, 2018 | Przybyl Arthur | President And CEO | Sale+OE | 23,986 | $61.23 | $1,468,694.54 | -3.6% | |
| Aug 22, 2016 | Przybyl Arthur | President And CEO | Sale+OE | 37,455 | $66.97 | $2,508,361.35 | -16.3% | |
| Aug 8, 2016 | Schrepfer Robert W | VP Bus Dev &Con Mfg | Sell | 12,500 | $67.06 | $838,208.75 | -41.9% |